Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2024-02-15 Board/Management Inform…
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Biotage utser Andrew Kellett till finanschef (CFO)
Board/Management Information Classification · 99% confidence The document is a short announcement, written in Swedish, stating that Andrew Kellett has been appointed as the permanent Chief Financial Officer (CFO) for Biotage, effective immediately, and is joining the group management. This directly concerns a change in senior management personnel. Based on the definitions, this aligns perfectly with the 'Board/Management Information' category (MANG). The document length is very short (1495 chars), but it is the primary announcement itself, not an announcement *about* another report, so RPA/RNS is not the primary fit.
2024-02-15 Swedish
Biotage appoints Andrew Kellett as CFO
Board/Management Information Classification · 100% confidence The document text is a short announcement (1473 characters) detailing the permanent appointment of Andrew Kellett as CFO of Biotage, effective immediately, and includes contact information and a brief company description. This content directly relates to a change in senior management personnel. This matches the definition for Board/Management Information (MANG). It is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2024-02-15 English
Biotages vd och koncernchef lämnar sitt uppdrag
Board/Management Information Classification · 100% confidence The document text explicitly announces that the CEO and Group President (vd och koncernchef) of Biotage is leaving immediately and names an interim replacement. This directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in senior management. The text is a formal announcement regarding executive leadership change.
2024-01-04 Swedish
Biotage CEO & President steps down from his role
Board/Management Information Classification · 99% confidence The document explicitly announces the immediate departure of the CEO & President, Tomas Blomquist, and the appointment of an interim CEO, Torben Jørgensen. It also details changes in the Chairman role. This content directly relates to changes in senior management and the board of directors. Therefore, the most appropriate classification is Board/Management Information (MANG). The document is short and appears to be a formal announcement, not a full report, confirming it is an announcement of management change.
2024-01-04 English
Major Shareholding Notification 2023
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding for an issuer (Biotage AB) by a holder (Invesco Ltd.). Specifically, it shows the 'Before the transaction' and 'After the transaction' share quantities, the reason for the notification ('Sell'), and the resulting percentage of voting rights (4.75648%). This structure is characteristic of a Major Shareholding Notification, where an entity reports crossing or moving below a specific threshold of ownership. This aligns directly with the definition for Major Shareholding Notification (MRQ). The document is not a full annual report (10-K), an earnings release (ER), or a director's dealing (DIRS), as it concerns an institutional holder's stake, not an executive's personal trade.
2023-12-26 English
Major Shareholding Notification 2023
Major Shareholding Notification Classification · 98% confidence The document details a change in shareholding percentage for an issuer (Biotage AB) by a holder (Invesco Ltd.). It explicitly lists the 'Before the transaction' and 'After the transaction' quantities of shares and voting rights, showing a change that crosses a threshold (implied by the structure, as the resulting percentage is reported). This structure, focusing on insider/major shareholder transactions and resulting ownership percentages, strongly aligns with the definition of Director's Dealing (DIRS) or Major Shareholding Notification (MRQ). Since the holder is 'Invesco Ltd.' (an investment manager) and the content is a formal notification of holding changes, it fits the 'Major Shareholding Notification' (MRQ) category better than DIRS (which is typically for directors/executives). The document is a direct notification of a holding change, not an announcement of a report (RPA/RNS).
2023-11-10 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.